Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

Creative Commons License

Nguyen A., Havrdova E. K., Horakova D., Izquierdo G., Kalincik T., van der Walt A., ...Daha Fazla

MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.28, ss.235-243, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.msard.2019.01.003
  • Dergi Adı: MULTIPLE SCLEROSIS AND RELATED DISORDERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.235-243
  • Anahtar Kelimeler: Multiple sclerosis, Pregnancy, Incidence, Therapy, Outcomes, FETAL OUTCOMES, POPULATION, DRUGS, DELIVERY, TIME, RISK, SEX
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background: Exposure to disease-modifying therapy (DMT) during early pregnancy in women with relapsing-remitting MS (RAMS) may be increasing.